Data from Partha Kar - Curated by EPG Health - Last updated 07 April 2017

You could call it the Batman syndrome. Actually you could call it anything you like - anything which would take the pathology away from being wrapped in the same paradigm of “diabetes”. I am talking about type 1 diabetes - and in the main, at least in the UK, this particular condition has been subsumed by the overarching realms of type 2 diabetes.

2 different pathologies, 2 different ways of treating, 2 different needs - yet in the main, in this country, due to some reason of convenience or lack of leadership from the specialist body, we have continued to badge them together. Type 2 diabetes is managed primarily by practice nurses - with support from GP colleagues and secondary care where appropriate - with the treatment ethos being different - the priorities of glucose control being variable depending on duration of pathology, other morbidities, along with a general dearth of hard outcome measures. On the other hand, type 1 diabetes is an autoimmune condition, needing tight glucose control, access to technology, different targets to achieve, different challenges - it makes little sense for both these pathologies to be lumped as one.

The media doesn’t help either - the number of times I see or hear type 1 patients or their parents stigmatised by comments of “should have eaten less” is not too uncommon - an immensely frustrating situation when you have developed a pathology due to autoimmune condition - rather than mainly via lifestyle issues. A 21 year old type 1 diabetes patient does not need a statin for a slightly raised cholesterol. Apart from the potential teratogenicity in a woman, it is not evidence based either.

So perhaps it’s time to either rename the condition or separate the 2 pathologies - in the way it is managed, in the way it is commissioned - lock, stock and barrel. It’s an important question to raise whether in a “free” healthcare system, choice takes a backseat or not. Should all type 1 diabetes patients be under specialist care - let me clarify - I don’t mean hospitals per se - I mean the personnel, their location could be anywhere per se. Due to the inevitability of demand, GPs, quite rightly, are the vanguards or as per an often used analogy, the robust gatekeepers to the people demanding to see the wizard. Does type 1 diabetes lend itself to that - should all type 1 patients have access to specialist care - and thus be considered earlier for pumps, psychology support, higher expertise - expertise that’s fundamentally different from type 2 diabetes care?

Recent studies show the reduced life expectancy in type 1 diabetes population - and it’s a genuine question as to whether we do enough as a healthcare community to improve their care. In the next part, I would like to discuss some possible options which could look at changing the paradigm of care for this group of patients - as things stand, we need to do better, much better than we are. If you aren’t convinced, just have a look at social media. The cry for help and support is loud and clear.


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Cardiovascular Metabolism Knowledge Centre

Cardiovascular Metabolism Knowledge Centre

The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.

Sleep Apnea

Sleep Apnea

Sleep apnea is a chronic condition characterised by recurrent interruptions in breathing throughout the sleep cycle. Learn about the two main types of sleep apnea and hear from experts as they present the latest research at the Sleep and Breathing conference (Marseille, 2019).

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Load more

Blog posts by Partha Kar

Type 1 diabetes: Changing the mould (part 2)

In this article, I try to look at how the usual elephants in the room can be challenged as regards type 1 diabetes care. Should Type 1 diabetes sit with primary care? Who is actually trained to look at this populace nowadays tagged in with type 2 diabetes? Are all specialists trained either? and why do we always think that under specialist care has to mean based inside a hospital? 

The time is perhaps right to look at all the audit data and stand up to say that the present system does need a change to improve care. the million dollar question however is whether we can do so beyond the politics and whether the appetite is there either

Posted 4 years ago

Changing paradigms for Diabetes care in Britain's NHS

Diabetes care is a hot topic in medicine since it touches so many primary care settings; from maternity to foot care, Diabetes has multiple other pathologies. When does Diabetes care necessitate the role of a specialist? How can diabetologists ensure they work innovatively and make the patient's healthcare journey as seamless as possible? Dr. Partha Kar dives in, asking how healthcare professionals can make positive change to patients with Diabetes in Britain's NHS.

Posted 5 years ago

Related Content